{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T14:54:10Z","timestamp":1778165650103,"version":"3.51.4"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T00:00:00Z","timestamp":1714089600000},"content-version":"am","delay-in-days":695,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA232056"],"award-info":[{"award-number":["R01 CA232056"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA227433"],"award-info":[{"award-number":["R01CA227433"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000179","name":"Office of the Director","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000179","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007161","name":"Boston University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007161","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["S10OD024993"],"award-info":[{"award-number":["S10OD024993"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32EB006359"],"award-info":[{"award-number":["T32EB006359"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.biomaterials.2022.121534","type":"journal-article","created":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T19:30:27Z","timestamp":1650483027000},"page":"121534","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Ultra-high drug loading improves nanoparticle efficacy against peritoneal mesothelioma"],"prefix":"10.1016","volume":"285","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4335-5384","authenticated-orcid":false,"given":"Robert C.","family":"Sabatelle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5876-1986","authenticated-orcid":false,"given":"Rong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8568-1591","authenticated-orcid":false,"given":"Yin P.","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7076-7560","authenticated-orcid":false,"given":"Eric","family":"Bressler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliza J.","family":"Neal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7512-5049","authenticated-orcid":false,"given":"Andrew","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iriny","family":"Ekladious","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5453-3668","authenticated-orcid":false,"given":"Mark W.","family":"Grinstaff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8229-5636","authenticated-orcid":false,"given":"Yolonda L.","family":"Colson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2022.121534_bib1","doi-asserted-by":"crossref","first-page":"120","DOI":"10.21037\/tlcr.2019.12.15","article-title":"Peritoneal mesothelioma","volume":"9","author":"Greenbaum","year":"2020","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.biomaterials.2022.121534_bib2","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1016\/S1470-2045(18)30100-1","article-title":"Review Novel therapies for malignant pleural mesothelioma","volume":"19","author":"Scherpereel","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.biomaterials.2022.121534_bib3","series-title":"Mesothelioma : Scientific Clues for Prevention , Diagnosis , and Therapy","first-page":"402","author":"Carbone","year":"2019"},{"key":"10.1016\/j.biomaterials.2022.121534_bib4","doi-asserted-by":"crossref","first-page":"839","DOI":"10.21873\/anticanres.13183","article-title":"Malignant peritoneal mesothelioma : treatment options and survival","volume":"39","author":"Salo","year":"2019","journal-title":"Anticancer Res."},{"key":"10.1016\/j.biomaterials.2022.121534_bib5","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1245\/s10434-019-08138-5","article-title":"Predictors and outcomes of surgery in peritoneal mesothelioma: an analysis of 2000 patients from the National cancer database","volume":"27","author":"Bijelic","year":"2020","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.biomaterials.2022.121534_bib6","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ejca.2016.06.002","article-title":"Diffuse malignant peritoneal mesothelioma: evaluation of systemic chemotherapy with comprehensive treatment through the RENAPE Database: multi-Institutional Retrospective Study","volume":"65","author":"Kepenekian","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.biomaterials.2022.121534_bib7","first-page":"599","volume":"vol. 7","author":"Sugarbaker","year":"2018"},{"key":"10.1016\/j.biomaterials.2022.121534_bib8","first-page":"333","article-title":"Treatment of malignant peritoneal mesothelioma","volume":"32","author":"Lev\u00fd","year":"2019","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.biomaterials.2022.121534_bib9","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0022-5223(99)70469-1","article-title":"Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients","volume":"117","author":"Sugarbaker","year":"1999","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.biomaterials.2022.121534_bib10","doi-asserted-by":"crossref","first-page":"6237","DOI":"10.1200\/JCO.2009.23.9640","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience","volume":"27","author":"Yan","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.biomaterials.2022.121534_bib11","doi-asserted-by":"crossref","DOI":"10.1177\/10600280940280S504","article-title":"Pharmacology and pharmacokinetics of paclitaxel","volume":"28","author":"Kuhn","year":"1994","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.biomaterials.2022.121534_bib12","first-page":"1237","article-title":"Influence of cremophor EL on the bioavailability of intraperitoneal paclitaxel","volume":"8","author":"Gelderblom","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biomaterials.2022.121534_bib13","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.ejso.2017.01.009","article-title":"Long-term regional chemotherapy for patients with epithelial malignant peritoneal mesothelioma results in improved survival","volume":"43","author":"Sugarbaker","year":"2017","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.biomaterials.2022.121534_bib14","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.suronc.2020.01.009","article-title":"Unusually favorable outcome of 6 consecutive patients with diffuse malignant peritoneal mesothelioma treated with repeated doses of intraperitoneal paclitaxel. A case series","volume":"33","author":"Sugarbaker","year":"2020","journal-title":"Surg. Oncol."},{"key":"10.1016\/j.biomaterials.2022.121534_bib15","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1515\/pp-2017-0012","article-title":"Normothermic intraperitoneal chemotherapy long term (NIPEC-LT) in the management of peritoneal surface malignancy, an overview","volume":"2","author":"Sugarbaker","year":"2017","journal-title":"Pleura Peritoneum"},{"key":"10.1016\/j.biomaterials.2022.121534_bib16","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1080\/17425247.2019.1693997","article-title":"Intraperitoneal delivery of chemotherapeutic agents for the treatment of peritoneal metastases: current challenges and how to overcome them","volume":"16","author":"Sugarbaker","year":"2019","journal-title":"Expet Opin. Drug Deliv."},{"key":"10.1016\/j.biomaterials.2022.121534_bib17","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.surg.2013.01.001","article-title":"Treatment factors associated with long-term survival after cytoreductive surgery and regional chemotherapy for patients with malignant peritoneal mesothelioma","volume":"153","author":"Alexander","year":"2010","journal-title":"Surgery"},{"key":"10.1016\/j.biomaterials.2022.121534_bib18","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S0959-8049(01)00171-X","article-title":"The drawbacks and advantages of vehicle selection for drug formulation","volume":"37","author":"Gelderblom","year":"2001","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.biomaterials.2022.121534_bib19","first-page":"2112","article-title":"Nonlinear pharmacokinetics of paclitaxel in mice results from the pharmaceutical vehicle cremophor EL","volume":"56","author":"Sparreboom","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.biomaterials.2022.121534_bib20","doi-asserted-by":"crossref","first-page":"11147","DOI":"10.1021\/acs.chemrev.5b00116","article-title":"Clinical translation of nanomedicine","volume":"115","author":"Min","year":"2015","journal-title":"Chem. Rev."},{"key":"10.1016\/j.biomaterials.2022.121534_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2011.11.031","article-title":"Local drug delivery strategies for cancer treatment: gels, nanoparticles, polymeric films, rods, and wafers","volume":"159","author":"Wolinsky","year":"2012","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2022.121534_bib22","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nrd2591","article-title":"Strategies in the design of nanoparticles for therapeutic applications","volume":"9","author":"Petros","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biomaterials.2022.121534_bib23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biomaterials.2022.121534_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/btm2.10143","article-title":"Nanoparticles in the clinic: an update","volume":"4","author":"Anselmo","year":"2019","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.biomaterials.2022.121534_bib25","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.addr.2019.04.008","article-title":"Concepts of nanoparticle cellular uptake, intracellular trafficking, and kinetics in nanomedicine","volume":"143","author":"Donahue","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2022.121534_bib26","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.addr.2012.10.003","article-title":"Advanced materials and processing for drug delivery: the past and the future","volume":"65","author":"Zhang","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2022.121534_bib27","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.addr.2013.11.009","article-title":"Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology","volume":"66","author":"Bertrand","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2022.121534_bib28","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41565-019-0626-4","article-title":"Transformable peptide nanoparticles arrest HER2 signalling and cause cancer cell death in vivo","volume":"15","author":"Zhang","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.biomaterials.2022.121534_bib29","doi-asserted-by":"crossref","first-page":"6006","DOI":"10.1016\/j.biomaterials.2009.07.015","article-title":"A self-assembling nanoparticle for paclitaxel delivery in ovarian cancer","volume":"30","author":"Xiao","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2022.121534_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.colsurfb.2009.09.001","article-title":"Biodegradable polymeric nanoparticles based drug delivery systems","volume":"75","author":"Kumari","year":"2010","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.biomaterials.2022.121534_bib31","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jconrel.2008.05.010","article-title":"Albumin as a drug carrier : design of prodrugs , drug conjugates and nanoparticles","volume":"132","author":"Kratz","year":"2008","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2022.121534_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-016-2671-9","article-title":"NAB-paclitaxel and gemcitabine in metastatic pancreatic ductal adenocarcinoma (PDAC): from clinical trials to clinical practice","volume":"16","author":"De Vita","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.biomaterials.2022.121534_bib33","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ctrv.2016.09.004","article-title":"Nab-paclitaxel for the treatment of triple-negative breast cancer: rationale, clinical data and future perspectives","volume":"50","author":"Schettini","year":"2016","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.biomaterials.2022.121534_bib34","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/14656566.2018.1546290","article-title":"Nanoparticle albumin bound-paclitaxel for treatment of advanced non-small cell lung cancer: an evaluation of the clinical evidence","volume":"20","author":"Adrianzen Herrera","year":"2019","journal-title":"Expet Opin. Pharmacother."},{"key":"10.1016\/j.biomaterials.2022.121534_bib35","first-page":"99","article-title":"Albumin-bound formulation of paclitaxel (Abraxane\u00ae ABI-007) in the treatment of breast cancer","volume":"4","author":"Miele","year":"2009","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biomaterials.2022.121534_bib36","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jconrel.2013.05.041","article-title":"Nab -Paclitaxel mechanisms of action and delivery","volume":"170","author":"Yardley","year":"2013","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2022.121534_bib37","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1021\/acscentsci.6b00150","article-title":"In vivo bioorthogonal chemistry enables local hydrogel and systemic pro-drug to treat soft tissue sarcoma","volume":"2","author":"Oneto","year":"2016","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.biomaterials.2022.121534_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-020-01669-1","article-title":"An NMR protocol for in vitro paclitaxel release from an albumin-bound nanoparticle formulation","volume":"21","author":"Suh","year":"2020","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.biomaterials.2022.121534_bib39","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1158\/1078-0432.CCR-07-4592","article-title":"Randomized crossover pharmacokinetic study of solvent-based paclitaxel and nab-paclitaxel","volume":"14","author":"Gardner","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biomaterials.2022.121534_bib40","first-page":"1","article-title":"A novel preparative method for nanoparticle albumin-bound paclitaxel with high drug loading and its evaluation both in vitro and in vivo","volume":"16","author":"Gao","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.biomaterials.2022.121534_bib41","doi-asserted-by":"crossref","first-page":"78208","DOI":"10.18632\/oncotarget.20596","article-title":"Nanoparticle as a novel tool in hyperthermic intraperitoneal and pressurized intraperitoneal aerosol chemotherapy to treat patients with peritoneal carcinomatosis","volume":"8","author":"Nowacki","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.biomaterials.2022.121534_bib42","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejso.2019.03.035","article-title":"Pharmacokinetics of the intraperitoneal nanoparticle pegylated liposomal doxorubicin in patients with peritoneal metastases","volume":"47","author":"Sugarbaker","year":"2021","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.biomaterials.2022.121534_bib43","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1158\/1535-7163.MCT-15-0713-T","article-title":"Paclitaxel-loaded polymersomes for enhanced intraperitoneal chemotherapy","volume":"15","author":"Sim\u00f3n-Gracia","year":"2016","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.biomaterials.2022.121534_bib44","doi-asserted-by":"crossref","first-page":"6006","DOI":"10.1016\/j.biomaterials.2009.07.015","article-title":"A self-assembling nanoparticle for paclitaxel delivery in ovarian cancer","volume":"30","author":"Xiao","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2022.121534_bib45","doi-asserted-by":"crossref","first-page":"25174","DOI":"10.1021\/acsami.8b08125","article-title":"Paclitaxel-loaded self-assembled lipid nanoparticles as targeted drug delivery systems for the treatment of aggressive ovarian cancer","volume":"10","author":"Zhai","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.biomaterials.2022.121534_bib46","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.jtcvs.2015.02.020","article-title":"Paclitaxel-loaded expansile nanoparticles enhance chemotherapeutic drug delivery in mesothelioma 3-dimensional multicellular spheroids","volume":"149","author":"Lei","year":"2015","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.biomaterials.2022.121534_bib47","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.biomaterials.2010.09.059","article-title":"The performance of expansile nanoparticles in a murine model of peritoneal carcinomatosis","volume":"32","author":"Colson","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2022.121534_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.athoracsur.2011.04.106","article-title":"Paclitaxel-loaded expansile nanoparticles in a multimodal treatment model of malignant mesothelioma","volume":"92","author":"Schulz","year":"2011","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.biomaterials.2022.121534_bib49","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.athoracsur.2010.12.040","article-title":"Paclitaxel-loaded expansile nanoparticles delay local recurrence in a heterotopic murine non-small cell lung cancer model","volume":"91","author":"Liu","year":"2011","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.biomaterials.2022.121534_bib50","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1016\/j.jtcvs.2019.12.076","article-title":"Paclitaxel-loaded expansile nanoparticles improve survival following cytoreductive surgery in pleural mesothelioma xenografts","volume":"160","author":"Chu","year":"2020","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.biomaterials.2022.121534_bib51","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1021\/ja807416t","article-title":"Expansile nanoparticles: synthesis, characterization, and in vivo efficacy of an acid-responsive polymeric drug delivery system","volume":"131","author":"Griset","year":"2009","journal-title":"Jacs"},{"key":"10.1016\/j.biomaterials.2022.121534_bib52","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.biomaterials.2016.06.031","article-title":"Nanoparticle tumor localization, disruption of autophagosomal trafficking, and prolonged drug delivery improve survival in peritoneal mesothelioma","volume":"102","author":"Liu","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2022.121534_bib53","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.biomaterials.2010.09.059","article-title":"The performance of expansile nanoparticles in a murine model of peritoneal carcinomatosis","volume":"32","author":"Colson","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2022.121534_bib54","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.2147\/IJN.S132780","article-title":"High drug-loading nanomedicines: progress, current status, and prospects","volume":"12","author":"Shen","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biomaterials.2022.121534_bib55","doi-asserted-by":"crossref","first-page":"8443","DOI":"10.1039\/C7SC03501B","article-title":"Synthesis of poly(1,2-glycerol carbonate)-paclitaxel conjugates and their utility as a single high-dose replacement for multi-dose treatment regimens in peritoneal cancer","author":"Ekladious","year":"2017","journal-title":"Chem. Sci."},{"key":"10.1016\/j.biomaterials.2022.121534_bib56","doi-asserted-by":"crossref","first-page":"8360","DOI":"10.1039\/C8NR01978A","article-title":"Reinforcement of polymeric nanoassemblies for ultra-high drug loadings, modulation of stiffness and release kinetics, and sustained therapeutic efficacy","volume":"10","author":"Ekladious","year":"2018","journal-title":"Nanoscale"},{"key":"10.1016\/j.biomaterials.2022.121534_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0055697","article-title":"A study on the interaction of rhodamine B with methylthioadenosine phosphorylase protein sourced from an Antarctic soil metagenomic library","volume":"8","author":"Bartasun","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biomaterials.2022.121534_bib58","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/00001813-199708000-00008","article-title":"Anti-tumor efficacy and biodistribution of intravenous polymeric micellar paclitaxel","volume":"8","author":"Zhang","year":"1997","journal-title":"Anti Cancer Drugs"},{"key":"10.1016\/j.biomaterials.2022.121534_bib59","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41573-018-0005-0","article-title":"Polymer\u2013drug conjugate therapeutics: advances, insights and prospects","volume":"18","author":"Ekladious","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biomaterials.2022.121534_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-51419-y","article-title":"Preclinical evaluation of local prolonged release of paclitaxel from gelatin microspheres for the prevention of recurrence of peritoneal carcinomatosis in advanced ovarian cancer","volume":"9","author":"De Clercq","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biomaterials.2022.121534_bib61","doi-asserted-by":"crossref","first-page":"6806","DOI":"10.1021\/ja402558m","article-title":"Synthesis of atactic and isotactic poly(1,2-glycerol carbonate)s: degradable polymers for biomedical and pharmaceutical applications","volume":"135","author":"Zhang","year":"2013","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biomaterials.2022.121534_bib62","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nmat4497","article-title":"Self-assembled RNA-triple-helix hydrogel scaffold for microRNA modulation in the tumour microenvironment","volume":"15","author":"Conde","year":"2016","journal-title":"Nat. Mater."},{"key":"10.1016\/j.biomaterials.2022.121534_bib63","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2567.2005.02253.x","article-title":"Selective inhibition by rottlerin of macropinocytosis in monocyte-derived dendritic cells","volume":"116","author":"Sarkar","year":"2005","journal-title":"Immunology"},{"key":"10.1016\/j.biomaterials.2022.121534_bib64","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/BF00685714","article-title":"Metabolism and elimination of rhodamine 123 in the rat","volume":"27","author":"Sweatman","year":"1990","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.biomaterials.2022.121534_bib65","first-page":"1035","article-title":"Comparative in vivo studies with paclitaxel and liposome-encapsulated paclitaxel","volume":"12","author":"Cabanes","year":"1998","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.biomaterials.2022.121534_bib66","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ijpharm.2007.02.011","article-title":"Enhanced solubility and stability of PEGylated liposomal paclitaxel: in vitro and in vivo evaluation","volume":"338","author":"Yang","year":"2007","journal-title":"Int. J. Pharm."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961222001740?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961222001740?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T17:09:01Z","timestamp":1758906541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961222001740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":66,"alternative-id":["S0142961222001740"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121534","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ultra-high drug loading improves nanoparticle efficacy against peritoneal mesothelioma","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121534","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"121534"}}